PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wuling Motors Holdings Limited (0305.HK)
0.690.03 (-4.17%)
0.68 - 0.75
0.33 - 0.86
13.79M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.49%
Negative revenue growth while 3606.HK stands at 12.35%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.93%
Negative gross profit growth while 3606.HK is at 12.34%. Joel Greenblatt would examine cost competitiveness or demand decline.
-38.09%
Negative EBIT growth while 3606.HK is at 16.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-38.09%
Negative operating income growth while 3606.HK is at 9.57%. Joel Greenblatt would press for urgent turnaround measures.
-46.61%
Negative net income growth while 3606.HK stands at 21.71%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-58.14%
Negative EPS growth while 3606.HK is at 22.22%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-58.14%
Negative diluted EPS growth while 3606.HK is at 22.22%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
27.41%
Share count expansion well above 3606.HK's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
27.49%
Diluted share change of 27.49% while 3606.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-60.86%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-86.70%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
60253.69%
10Y revenue/share CAGR above 1.5x 3606.HK's 482.72%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-22.50%
Negative 5Y CAGR while 3606.HK stands at 86.82%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-3.23%
Negative 3Y CAGR while 3606.HK stands at 43.81%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
1252.02%
10Y OCF/share CAGR above 1.5x 3606.HK's 249.91%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
382.08%
OCF/share CAGR of 382.08% while 3606.HK is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
1336.12%
3Y OCF/share CAGR of 1336.12% while 3606.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
334.84%
Net income/share CAGR at 50-75% of 3606.HK's 655.45%. Martin Whitman might question if the firm’s product or cost base lags behind.
115.27%
5Y net income/share CAGR above 1.5x 3606.HK's 30.28%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
911.33%
3Y net income/share CAGR above 1.5x 3606.HK's 94.26%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
326.15%
5Y equity/share CAGR above 1.5x 3606.HK's 103.17%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
52.13%
3Y equity/share CAGR 1.25-1.5x 3606.HK's 47.22%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 3606.HK stands at 115.25%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-14.25%
Firm’s AR is declining while 3606.HK shows 10.17%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
19.80%
We show growth while 3606.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-6.28%
Negative asset growth while 3606.HK invests at 2.51%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-19.68%
We have a declining book value while 3606.HK shows 5.90%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-40.86%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-10.61%
Our R&D shrinks while 3606.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.66%
We expand SG&A while 3606.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.